The 20 Best Relapsed Refractory Multiple Myeloma (RRMM) Doctors near Greenbrae, CA

A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Ajai Chari is an Oncologist in San Francisco, California. Dr. Chari is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Jennifer Lucas is an Oncologist in Greenbrae, California. Dr. Lucas is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Small Lymphocytic Lymphoma (SLL), and Diffuse Large B-Cell Lymphoma (DLBCL).

Barbara Galligan is a Hematologist in Greenbrae, California. Dr. Galligan has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Joseph Poen is a Radiation Oncologist in Greenbrae, California. Dr. Poen is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Polymorphous Low Grade Adenocarcinoma, Anal Cancer, Pleuropulmonary Blastoma, and Cholangiocarcinoma (Bile Duct Cancer).

Kristin Anderson is a Hematologist in Greenbrae, California. Dr. Anderson has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Polycythemia Vera, and Chronic Lymphocytic Leukemia (CLL).

Alex Metzger is a Hematologist in Greenbrae, California. Dr. Metzger is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Polycythemia Vera, Familial Colorectal Cancer, Familial Prostate Cancer, Urothelial Cancer, and Bone Marrow Aspiration.

Peter Eisenberg is an Internal Medicine provider in Greenbrae, California. Dr. Eisenberg is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Ovarian Cancer, Colorectal Cancer, Lung Cancer, and Ovarian Carcinosarcoma.

Bobbie Head is an Oncologist in Greenbrae, California. Dr. Head has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.

Dr. Thomas M. Link is chief of the musculoskeletal imaging section in the UCSF Department of Radiology and Biomedical Imaging. As clinical director of the department's Musculoskeletal Quantitative Imaging Research (MQIR) group, he has a strong interest in translational research (using study findings to establish new treatments or diagnostic methods). The main focuses of MQIR are: imaging of osteoporosis, particularly developing new techniques for assessing bone quality and density; applying new imaging techniques to the assessment of osteoarthritis and cartilage, and to preventing cartilage degeneration; new imaging sequences for musculoskeletal imaging at high field; and MR-guided high-intensity focused ultrasound for treatment of bony abnormalities. Link earned his medical degree at Johannes Gutenberg University Mainz in Germany. He completed his medical residency in Münster, Germany. He completed a research fellowship in radiology at UCSF. Link was a vice chair in the radiology department at the Technical University of Munich before joining UCSF in 2003. Dr. Link is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Sandhaus Ben-Ami Syndrome, Synovitis, MAGIC Syndrome, Endoscopy, and Hip Replacement.

Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007. Dr. Wolf is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Nancy Sze Wan Wong is a nurse practitioner who cares for patients with blood disorders. Her expertise includes chronic blood disorders that surface suddenly and require immediate treatment. Wong is passionate about caring for patients with cancers of the blood. She aims to help her patients learn more about their condition in addition to helping them manage their symptoms during recovery. Wong earned her master's degree in nursing at Samuel Merritt University. She is a member of the Oncology Nursing Society. A native of San Francisco, Wong enjoys spending time with her family, reading and hiking. Ms. Wong is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM) and Smoldering Multiple Myeloma.

Dr. Shagun Arora is a hematologist-oncologist who specializes in caring for patients with malignant and classical (cancerous and noncancerous) blood disorders. She treats patients with diverse hematologic conditions in both categories. Her focus is monoclonal gammopathies, or conditions in which the blood contains abnormal proteins, including MGUS (monoclonal gammopathy of undetermined significance) and multiple myeloma, along with anemias. Arora's goal is to provide compassionate, supportive care that takes the whole person into consideration, while helping patients fight cancer. She considers it a privilege to be part of the lives of cancer patients and their families. In addition to patient care, she is passionate about medical education, working closely with training physicians who are pursuing fellowships in hematology and oncology. Arora is the medical director of the Infusion Center at UCSF's Parnassus campus. Arora completed her residency at Michigan State University, followed by a fellowship at MedStar Washington Hospital Center and MedStar Georgetown University Hospital, where she served as chief fellow. She is a member of several professional associations, including the American Society of Hematology, American Society of Clinical Oncology, Society of Hematologic Oncology and International Myeloma Society. In her free time, Arora enjoys international travel, yoga retreats and hiking to view the gorgeous vistas of San Francisco. Dr. Arora is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system. Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma. After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology. Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists. Dr. Chung is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Caring, compassionate, and patient centric care. Dr. Quock is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.

Dr. Kevin McGill is a radiologist who specializes in the musculoskeletal system. He interprets X-rays, dual-energy X-ray absorptiometry (DXA) scans, CT scans, MRIs and ultrasounds. He has a particular interest in using ultrasound to diagnose musculoskeletal conditions as well as for guiding procedures to treat them. McGill's research involves image-guided procedures and cancer-related imaging. He is also interested in medical applications of artificial intelligence and improving the utility of medical imaging so that unnecessary diagnostic exams are eliminated and minimally invasive treatments are optimized. At the UCSF Bakar Precision Cancer Medicine Building, he is developing the musculoskeletal ultrasound biopsy program. McGill earned his medical degree from the Feinberg School of Medicine at Northwestern University. He completed a residency in diagnostic radiology and a fellowship in musculoskeletal radiology at the Henry Ford Health System. In his free time, McGill enjoys traveling with his wife and kids. Dr. Mcgill is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Melorheostosis, Melorheostosis with Osteopoikilosis, Osteopenia, Chondrodystrophy, and Endoscopy.

Dr. Sigurd H. Berven has a strong interest in the care of children and adults with spinal disorders. He has expertise in pediatric and adult deformities, degenerative conditions of the spine, spinal tumors and spinal trauma. In research, Berven is interested in the assessment of outcomes for patients who have orthopedic surgery. He also studies minimally invasive techniques in spinal surgery, and he is exploring cellular and molecular techniques to biologically regenerate components of the spine, including the intervertebral disc. Berven studied human biology as an undergraduate at Stanford University. He was a graduate student in philosophy, politics and economics at the University of Oxford. He received his medical degree from Harvard Medical School and then completed his residency in the Harvard Combined Orthopaedic Residency Program, which provides training at four major city hospitals. Next, he advanced his training in spine surgery as a clinical fellow at UCSF and in pediatric orthopedic surgery as chief resident at Boston Children's Hospital. Often invited to speak at national and international conferences, Berven has lectured on topics including measurement of outcomes in spine surgery, evaluation and management of spinal disorders, and advanced techniques in spinal surgery. Dr. Berven is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Spondylolisthesis, Scoliosis, Kyphosis, Spinal Fusion, and Osteotomy.

Sandy Wong is a Hematologist in San Francisco, California. Dr. Wong has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.

Nina Shah is an Oncologist in San Francisco, California. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.